Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial
- 11 May 2022
- journal article
- research article
- Published by Elsevier BV in Endocrine
- Vol. 113 (5), 996-1002
- https://doi.org/10.1016/j.ijrobp.2022.04.024
Abstract
No abstract availableFunding Information
- Department of Atomic Energy, Government of India
This publication has 14 references indexed in Scilit:
- Long-term Outcomes and Complications in Pediatric Ewing SarcomaAmerican Journal of Clinical Oncology, 2017
- What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group – EWING1BMC Cancer, 2017
- Pelvis Ewing sarcoma: Local control and survival in the modern eraPediatric Blood & Cancer, 2017
- Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor ControlEndocrine, 2016
- Role of Radiotherapy in the Multimodal Treatment of Ewing Sarcoma Family TumorsCancer Research and Treatment, 2015
- Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology GroupCancer, 2014
- Long-Term Clinical and Functional Outcomes After Treatment for Localized Ewing's Tumor of the Lower ExtremityEndocrine, 2008
- Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trialsEndocrine, 2003
- Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.Journal of Clinical Oncology, 1996
- Radiation therapy in Ewing's sarcoma: An update of the CESS 86 trialEndocrine, 1995